About HDS / Global Partners

Hema Diagnostic Systems, as a member of the Global Business Coalition to Fight HIV/AIDS, TB and Malaria (GBC), seeks to assist governmental and non-governmental organizations in their fight against these three pandemics. Effective rapid diagnostic tests are one of the key tools to intervening in the spread of HIV/AIDS, tuberculosis and malaria around the world.

GBC UNITES BUSINESSES IN THE FIGHT AGAINST HIV/AIDS

Over the last five years, GBC has grown from 17 companies to over 200 international companies dedicated to fighting the AIDS pandemic by accessing the business sector's unique skills and expertise.

GBC’s four main goals facilitate its mission to harness the power of the global business community to end the HIV/AIDS, tuberculosis, and malaria epidemics:

Increase the number and diversity of companies committed to fighting global epidemics by engaging new businesses to join its extensive network of member companies.

Increase business action against HIV/AIDS, TB, and malaria, and improve the quality and reach of company and community programs. By leveraging their existing skills, products and networks, companies have a unique opportunity to respond to pandemics in myriad ways; GBC’s Business AIDS Methodology (BAM)™ enables each individual member company to develop an appropriate custom-made HIV/AIDS business plan and strategy, and its Best Practice AIDS Standard (BPAS)™ allows confidential monitoring and evaluation.

Enhance and facilitate the use of companies' core competencies and products in the fight against HIV/AIDS, TB, and malaria: GBC believes that regardless of its area of expertise and global location, the business sector can offer much more than financial support to end the HIV/AIDS, TB, and malaria epidemics. As such, GBC encourages members—especially those that do not have a direct bottom-line stake in disease prevention and treatment—to think outside the box and create innovative ways to fight HIV/AIDS, malaria, and TB. The organization facilitates this goal by fostering unique partnerships with NGOs, governments and civil society.

Use business power to advocate for HIV/AIDS, TB, and malaria issues and lead the epidemic’s response. GBC uses the private sector’s power to influence and shape public policy. It creates opportunities for business leaders to speak out on HIV/AIDS, TB, and malaria and enables companies to lend their name to the fight. In countries heavily affected by the epidemics, GBC encourages the business sector to partner with public sector officials and help coordinate national strategy.

http://www.businessfightsaids.org

Diagned (Diagnostic Association of the Netherlands) is a trade association for manufacturers and importers of in-vitro medical diagnostic tests who do business in the Netherlands (Holland). There are more than three dozen members in Diagned.

Hema Diagnostics joins such significant companies as Abbott, Bayer, Becton Dickinson, bioMerieux, and Roche Diagnostics as a member of this important organization.

The goals of Diagned are to focus attention on and foster discussion and knowledge of in-vitro diagnostic tests while strengthening the contacts between manufacturers and the users of these tests: patient organizations, testing centers, and insurers. Diagned also aims to have important dialogues between its members and the government to insure in-vitro diagnostics are understood and used to their full potential.